Detection of Epstein-Barr Virus DNA in Gastric Biopsies of Pediatric Patients with Dyspepsia
Authors:
- Abigail Morales-SánchezAMAbigail Morales-Sánchez
- Javier TorresJTJavier Torres
- María G. Cardenas-MondragónMCMaría G. Cardenas-Mondragón
- Carolina Romo-GonzálezCRCarolina Romo-González
- Margarita Camorlinga-PonceMCMargarita Camorlinga-Ponce
- Lourdes Flores-LunaLFLourdes Flores-Luna
- Ezequiel M. Fuentes-PananáEFEzequiel M. Fuentes-Pananá
Open Access
Abstract
In this study, we assessed the presence of Epstein-Barr virus (EBV) in gastric samples derived from pediatric patients with dyspeptic symptoms, aiming to understand whether EBV participates in the development of early gastric lesions influencing chronic inflammation, in conjunction with the Helicobacter pylori (Hp) bacterium. We analyzed EBV load in 236 gastric biopsies derived from 186 pediatric patients with chronic dyspepsia and compared it with EBV serology, Hp load and serology, and with immune cell infiltration. We found that 7.5% of patients were positive for EBV load, ranging from 240 to 29,685 genomic copies/μg of DNA. Hp genomic sequences were found in 24.7% of patients. EBV positive samples did not correlate with Hp status and were characterized by absent to moderate immune cell infiltration. To our knowledge, this is the first study addressing EBV load in the stomach in a large cohort of pediatric patients with dyspeptic symptoms, providing evidence of EBV localization in the gastric mucosa in early inflammatory lesions. The lack of correlation between EBV and both Hp infection and inflammation is perhaps explained by independent pathogenic mechanisms or because of the randomness of the gastritis sampling. This is also supported by a moderate association between EBV load and serology.Keywords
Funding Information
- Hospital Infantil de México Federico Gómez (HIM-2017-074)
This publication has 39 references indexed in Scilit:
- Epstein Barr Virus and Helicobacter pylori Co-Infection Are Positively Associated with Severe Gastritis in Pediatric PatientsPLOS ONE, 2013
- Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysisBritish Journal of Cancer, 2011
- Association of Epstein–Barr virus antibody levels with precancerous gastric lesions in a high‐risk cohortCancer Science, 2008
- Sustained elevation of Epstein–Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinomaBritish Journal of Cancer, 2007
- Helicobacter pylori-associated oxidant monochloramine induces reactivation of Epstein–Barr virus (EBV) in gastric epithelial cells latently infected with EBVJournal of Medical Microbiology, 2006
- Resting B cells as a transfer vehicle for Epstein–Barr virus infection of epithelial cellsProceedings of the National Academy of Sciences, 2006
- Single-Assay Combination of Epstein-Barr Virus (EBV) EBNA1- and Viral Capsid Antigen-p18-Derived Synthetic Peptides for Measuring Anti-EBV Immunoglobulin G (IgG) and IgA Antibody Levels in Sera from Nasopharyngeal Carcinoma Patients: Options for Field ScreeningJournal of Clinical Microbiology, 2006
- Epstein–Barr Virus–Related Gastric Adenocarcinoma: An Early Secondary Cancer Post Hemopoietic Stem Cell TransplantationGastroenterology, 2005
- The Dispersal of Mucosal Memory B CellsImmunity, 2002
- Specific Serum Immunoglobulin G Response to Urease and CagA Antigens of Helicobacter pylori in Infected Children and Adults in a Country with High Prevalence of InfectionClinical and Vaccine Immunology, 2002